助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   ovarian benign 的翻译结果: 查询用时:0.009秒
图标索引 在分类学科中查询
所有学科
肿瘤学
妇产科学
更多类别查询

图标索引 历史查询
 

ovarian benign
相关语句
  卵巢良性
     In ovarian benign epithelial tumors,borderline epithelial tumors and malignant epithelial tumors,the positive rates of MDM2 and p53 were 12.50% (1/8),28.59% (2/7) ,47.37% (9/19);
     [结果]在卵巢良性上皮性肿瘤、卵巢交界性上皮性肿瘤和卵巢癌中 ,MDM2的阳性表达率分别为 :12.50%(1/8)、28.59%(2/7)和47.37 %(9/19) ;
短句来源
     The retentionrates and relative contents of intron 9 in ovarian benign , borderline, and malignant tumor were 36.7%and 8.37%, 87.50% and 86.87%, 93 .33% and91.17%,respectively.
     在卵巢良性、交界性、恶性上皮性瘤中滞留率及相对含量分别为 3 6.67%和 8.3 7% ,87.50 %和86.87% ,93 .3 3 %和 91.17% ;
短句来源
     Result The positive rate of p65 expression in ovarian benign epithelial tumors, borderline epithelial tumors and malignant epithelial tumors was 26.7 %, 37.5 % and 72.5 % respectively;
     结果NFκB/p65蛋白呈现棕黄色、细颗粒状物,在卵巢良性上皮性肿瘤、卵巢交界性上皮性肿瘤和卵巢癌中NFκB的阳性表达率分别为:26.7%、37.5%和72.5%;
短句来源
     Results:In ovarian benign tumors、borderline epithelial tumors and malignant epithelial tumors,the positive rates of NFkB/P65 were 33.3%、37.5% and 65% respectively;
     结果 :在卵巢良性上皮性肿瘤、卵巢交界性上皮性肿瘤和卵巢癌中NFkB的阳性表达率分别为33 3 %、37 5 %和65 % ;
短句来源
     Metheds The serum CA125,AFP,CEA,CA19-9 were determinated by automated chemiluminescence assay in all 296 patients(including 47 cases of ovarian cancer,249 cases of ovarian benign diseases).
     方法 采集 2 96例住院患者的血清 ,其中卵巢癌 4 7例 ,卵巢良性病变 2 4 9例 ,用化学发光法检测其血清CA12 5、AFP、CEA、CA19 9值。
短句来源
更多       
  “ovarian benign”译为未确定词的双语例句
     Comparing recurrent ovarian cancer group with the ovarian benign tumor group, the difference between sPLA2 activity (26.53 ±6.05 U/L, 4.94 ±1.86 U/L)and LPA level(7.03 ±2.77, 1.92 ±0.75) was statistically (P<0.01).
     复发卵巢癌组与卵巢良性肿瘤组相比,sPLA2活性(26.53±6.05U/L与4.94±1.86U/L)和LPA水平(7.03±2.77mmol/L与1.92±0.75mmol/L)差异也均具有统计学意义(均P<0.01)。
短句来源
     Results For patients with ovarian malignant tumors,the mean CA125 and CA199 were(210±242.5)U/ml and(39.7±40.7)U/ml,the positive rate were 72.4% and 44.8%,respectively; which were significantly higher than those of patients with ovarian benign tumors(P<0.01 and P<0.05,respectively).
     结果卵巢恶性肿瘤患者血清中的CA125均值为(210±242.5)U/m l,阳性率72.4%,CA199均值为(39.7±40.7)U/m l,阳性率为44.8%,明显高于卵巢良性肿瘤患者,差异有显著性(P<0.01和P<0.05);
短句来源
     Result:Patients in ovarian carcinoma group had significantly higher plasma LPA levels (5.63±2.35)μmol/L compared with the ovarian benign disease group(2.80±1.13)μmol/L(P<0.01), and healthy control group (2.51±1.08) μmol/L(P<0.01).
     结果:卵巢恶性肿瘤,良性肿瘤及健康对照者血浆LPA水平分别为(5.63±2.35)μmol/L、(2.80±1.13)μmol/L(、2.51±1.08)μmol/L,前者血浆LPA水平与后两者相比,差异有统计学意义(P<0.01);
短句来源
     Results Patients in ovarian carcinoma group had significantly higher plasma LPA levels (5.63±2.35)μmol/L compared with the ovarian benign disease group(2.80±1.13)μmol/L(P<0.01), and healthy control group (2.51±1.08) μmol/L(P<0.01).
     结果卵巢恶性肿瘤患者、卵巢良性肿瘤患者及健康对照者血浆LPA水平分别为(5.63±2.35)μmol/L、(2.80±1.13)μmol/L、(2.51±1.08)μmol/L,前者血浆LPA水平与后两者相比,差异有统计学意义(P<0.01);
短句来源
     The positive rates of LPA-2 and LPA-3 receptor mRNA(95.7% and 91.3%) were significantly higher in epithelial ovarian neoplasms than in ovarian benign disease(21.3% and 21.3%) and normal ovarian tissue(15.4% and(15.4%)).
     上皮性卵巢癌组织LPA2mRNA、LPA3mRNA表达阳性率(95.7%;91.3%)显著高于良性卵巢肿瘤(21.3%;21.3%)及正常卵巢组织(15.4%;15.4%)(P<0.01);
短句来源
更多       
  相似匹配句对
     B. Benign;
     B.良性肿瘤:膨胀性骨破坏;
短句来源
     Enucleation of benign ovarian cysts by laparoscopy
     腹腔镜下良性卵巢囊肿剥出术术式探讨
短句来源
     Laparoscopic Surgery of Ovarian Benign Teratoma
     腹腔镜手术治疗卵巢良性畸胎瘤
短句来源
     OVARIAN AUTOTRANSPOSITION
     卵巢自体移植
短句来源
     OVARIAN PREGNANCY
     卵巢妊娠
短句来源
查询“ovarian benign”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


This study used a biochemical short-tern 3H-TdR incorporation assay, drug sensitivity test in vitro was detected in 54 patients with ovarian malignant tumor. 20 patients with ovarian benign tumor served as controls. The results suggested that there was a significant difference (P<0.001) the sensitivity of ovarian malignant tumor and that of ovarian benign tumor to chemotherapeutic drug(P<0.001). Among the 54 cases, the results of drug sensitivity test in vitro of 48 cases coincided with the...

This study used a biochemical short-tern 3H-TdR incorporation assay, drug sensitivity test in vitro was detected in 54 patients with ovarian malignant tumor. 20 patients with ovarian benign tumor served as controls. The results suggested that there was a significant difference (P<0.001) the sensitivity of ovarian malignant tumor and that of ovarian benign tumor to chemotherapeutic drug(P<0.001). Among the 54 cases, the results of drug sensitivity test in vitro of 48 cases coincided with the results of clinical therapy in 33 cases.The coincidence rate was 68.8%

本文用生化快速氚-胸腺嘧啶核苷(~3H-TdR)掺入法对54例卵巢恶性肿瘤进行体外药敏试验,并以20例卵巢良性肿瘤作对照。结果两者对化疗药物的敏感性差异有极显著性意义(P<0.001)。在54例中,48例体外药敏试验结果与临床疗效一致者33例,符合率为68.8%。

Sister chromatid exchange(SCE) frequencies of peripheral blood lymphocytes(PBLs) were studied in 27 patients with ovarian malignancies, 3 with ovarian borderline tumors, 20 with ovarian benign tumors and 10 with ovarian tumor-like lesions. The SCE value of patients with ovarian malignancies was 7.24±0.39/cell, which was significantly higher than that of healthy women (5.62±0.24), patients with ovarian tumor-like lesions(5.70±0.57) and ovarian benign tumors(5.70±0.40). There was...

Sister chromatid exchange(SCE) frequencies of peripheral blood lymphocytes(PBLs) were studied in 27 patients with ovarian malignancies, 3 with ovarian borderline tumors, 20 with ovarian benign tumors and 10 with ovarian tumor-like lesions. The SCE value of patients with ovarian malignancies was 7.24±0.39/cell, which was significantly higher than that of healthy women (5.62±0.24), patients with ovarian tumor-like lesions(5.70±0.57) and ovarian benign tumors(5.70±0.40). There was no significant difference between the SCE value of patients with ovarian borderline tumors (7.28±1.15) and that of patients with ovarian malignancies. Before treatment the SCE frequencies of patients with ovarian malignancies were not related to clinical staging and his-tological classification.The difference between the SCE values of ovarian malignancies in preoperative period and the values of 1-2 weeks following debulking surgery. Was not significant cellular kinetics in PBLs from patients with ovarian malignancies, expre ssed as average generation time(AGT),was significantly suppressed as compared to that of healthy women

本文对27例卵巢恶性肿瘤患者外周血进行姊妹染色单体交换(SCE)测定,结果为7.24±0.39次/细胞,显著高于正常妇女(5.62±0.24)、卵巢瘤样病变(5.70±0.57)和卵巢良性肿瘤(5.70±0.40),与卵巢交界性肿瘤(7.28±1.15)相近。卵巢恶性肿瘤患者淋巴细胞的平均世代时间(AGT)为27.03±0.86h,与正常妇女(24.91±0.59h)相比,差异有极显著意义(P<0.01)。

From June 1981 to June 1988, 353 cases of uterine leiomyoma were treated. Fifty three of them were women less than 35 years old. The tumors in this younger age group had large bulk accounting for 15%, and half of the latter large bulk tumors showed hyperplasia of myoma cells. Concurrently present were hyperplastic endometrium (38.85%), endometriosis(11.32%) and ovarian benign disease (16.98%). According to the patlentt's condition, different technic of operation could be chosen. In general, myomectomy...

From June 1981 to June 1988, 353 cases of uterine leiomyoma were treated. Fifty three of them were women less than 35 years old. The tumors in this younger age group had large bulk accounting for 15%, and half of the latter large bulk tumors showed hyperplasia of myoma cells. Concurrently present were hyperplastic endometrium (38.85%), endometriosis(11.32%) and ovarian benign disease (16.98%). According to the patlentt's condition, different technic of operation could be chosen. In general, myomectomy is the treatment of choice. For women who hope child bearing in the future, subtotal hysterectomy is easier to perform than total hysterectomy and the patient maintains the physiologic function when the patient is young.

自1981年6月~1988年6月。我院收治35岁以下的年青妇女子宫肌瘤53例。巨大肌瘤占15%。其中瘤细胞增生活跃占50%。并发子宫内膜增生过长35.85%,子宫肌腺病11.32%,卵巢良性病变16.98%。对年青妇女应根据具体情况而选择不同的术式。对未婚者和希望保留生育功能的妇女应做肌瘤摘除术。本文认为子宫次全切除术操作简单,并发症少又能保持阴道的生理功能,对年青患者此种术式优于全子宫切除术。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关ovarian benign的内容
在知识搜索中查有关ovarian benign的内容
在数字搜索中查有关ovarian benign的内容
在概念知识元中查有关ovarian benign的内容
在学术趋势中查有关ovarian benign的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社